NCT07334119 2026-05-20Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid TumorsMyeloid TherapeuticsPhase 1 Recruiting60 enrolled
NCT04389632 2026-05-11A Study of Sigvotatug Vedotin in Advanced Solid TumorsSeagen Inc.Phase 1 Recruiting1,006 enrolled